+91 97142 22533 , +91 97264 46270 [email protected]


Product Name : Brimonidine

Grade : IP / BP / USP

Therapeutic Category : Antiglaucoma

CAS No : 70359-46-5

COA : Available

MSDS : Available





  • Brimonidine is a drug used to treat open-angle glaucoma or ocular hypertension, and as a gel, Mirvaso, for facial skin redness in rosacea.

    • Appearance :- White to slightly yellowish powder
    • Solubility :-Soluble in water, slightly souluble in methanol
    • Identification :- HNMR,HPLC
    • Loss on drying :- ≤0.5%
    • pH:- 3.0~4.5
    • Melting point :- 205°C~210°C
    • Specific rotation :- + 9.0° ~ + 10.5°
    • Loss on drying:- ≤0.5%
    • Residue on ignition:- ≤ 0.1%
    • Heavy metals:- ≤10 ppm
    • Related substances :-
      Single impurity ≤0.2%
      Total impurities ≤0.5%
    • Assay(HPLC)-99%~101%
    • Total aerobic microbial count :
      Total bacterial count <100cfu/gr
      Total fungal<10cfu/gr

    Packaging details

    Packaging details: 25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.

    Storage: Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat.

    Shelf Life: 5 years if sealed and store away from direct sun light.


    Additional Information

    The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

    ASIA: Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Afghanistan, Israel, Jordan, Pakistan, Russia, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth..

    AFRICA: South Africa, Uganda, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, and so forth.

    NORTH & SOUTH AMERICA: Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela, USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Brazil, Bahamas, Ecuador, and so forth .

    EUROPE: France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

    OCEANIA: Fiji, Australia, New Zealand, and so forth.